![Patrick Lamy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Patrick Lamy worked at Gilead Sciences, Inc. from 2008 to 2018 as Head-Commercial Strategy & Banking.
From 2018 to 2021, worked at Iovance Biotherapeutics, Inc. as Vice President-Commercial.
From 2023 to 2025, worked at Akero Therapeutics, Inc. as Senior Vice President-Commercial Strategy.
Education includes an MBA from the University of California, Berkeley and an undergraduate degree from the University of California San Diego.
Antiguos cargos conocidos de Patrick Lamy.
| Empresas | Cargo | Fin |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | 09/12/2025 |
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2018 |
Formación de Patrick Lamy.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
45
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Patrick Lamy
